Lisa A. Shipley
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 7
- Drug-Induced Hepatotoxicity and Protection 3
-
- Drug Transport and Resistance Mechanisms 5
-
- Eicosanoids and Hypertension Pharmacology 2
- Statistics and Probability top 10%
-
- Medication Adherence and Compliance 2
-
- Biosimilars and Bioanalytical Methods 2
-
- Pharmaceutical studies and practices 2
-
- Viral gastroenteritis research and epidemiology 1
- Co-authors
- Steven WrightonMark VandenBrandenJeffrey StevensJohn R. CashmanBarbara J. RingAllan E. RettieMarissa F. DockendorfKevin P. Bateman
- Journals
- Drug Metabolism and Disposition (4 papers)Biochemical Pharmacology (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- United StatesSwedenDenmark
In The Last Decade
Lisa A. Shipley
20 papers receiving 554 citations
Peers
Comparison fields: 5 of 103
- Pharmacology 235
- Oncology 138
- Cellular and Molecular Neuroscience 81
- Biochemistry 27
- Statistics and Probability 30
Countries citing papers authored by Lisa A. Shipley
This map shows the geographic impact of Lisa A. Shipley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa A. Shipley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa A. Shipley more than expected).
Fields of papers citing papers by Lisa A. Shipley
This network shows the impact of papers produced by Lisa A. Shipley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa A. Shipley. The network helps show where Lisa A. Shipley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lisa A. Shipley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 26 | |
| 2 | 2020 | 42 | |
| 3 | 2018 | 15 | |
| 4 | 2016 | 38 | |
| 5 | 2013 | 1 | |
| 6 | 2008 | 37 | |
| 7 | 2003 | 7 | |
| 8 | 2000 | 10 | |
| 9 | 1997 | 1 | |
| 10 | 1997 | 39 | |
| 11 | 1997 | 3 | |
| 12 | 1997 | 89 | |
| 13 | Intratumor pharmacokinetics, flow resistance, and metabolism during gemcitabine infusion in ex vivo perfused human small cell lung cancer. | 1996 | 23 |
| 14 | 1995 | 1 | |
| 15 | 1994 | 2 | |
| 16 | 1993 | 62 | |
| 17 | 1993 | 146 | |
| 18 | 1988 | 6 | |
| 19 | 1985 | 4 | |
| 20 | 1984 | 13 |
About Lisa A. Shipley
Lisa A. Shipley is a scholar working on Family Practice, Pharmacology and Biochemistry, having authored 22 papers that have together received 581 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (5 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Medication Adherence and Compliance (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Pharmaceutical studies and practices (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Pharmacology (235 citations), Oncology (138 citations) and Cellular and Molecular Neuroscience (81 citations). Lisa A. Shipley has collaborated with scholars based in United States, Sweden and Denmark. Frequent co-authors include Steven Wrighton, Mark VandenBranden, Jeffrey Stevens, John R. Cashman, Barbara J. Ring, Allan E. Rettie, Marissa F. Dockendorf, Kevin P. Bateman, Bryan J. Hansen and Jyoti Shah. Their work appears in journals such as Drug Metabolism and Disposition, Biochemical Pharmacology, Journal of Medicinal Chemistry, Clinical Pharmacology & Therapeutics and Drug Metabolism Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.